D. E. Shaw & Co., Inc. Sellas Life Sciences Group, Inc. Transaction History

D. E. Shaw & Co., Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$2.14 - $4.15 $47,264 - $91,656	-22,086 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$4.73 - $7.18 $13,920 - $21,130	2,943 Added 15.37%	22,086 $148,000
Q4 2021 Feb 14, 2022	SELL	$5.36 - $9.53 $57,770 - $102,714	-10,778 Reduced 36.02%	19,143 $106,000
Q3 2021 Nov 15, 2021	SELL	$8.21 - $10.53 $18,004 - $23,092	-2,193 Reduced 6.83%	29,921 $274,000
Q2 2021 Aug 16, 2021	BUY	$7.19 - $13.71 $230,899 - $440,282	32,114 New	32,114 $356,000

5.69M

1.67M

74.7K

Ticker SLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,551,900
Market Cap $19.5M
Description
SELLAS Life Sciences Group, Inc., a late-stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications in the United States. Its lead product candidate is galinpepimut-S (GPS), a cancer immunotherapeutic agent that targets Wilms tumor 1, which is in Phase III clinical trials for the tr...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.